Laddar...
Achieving Neuroprotection with LRRK2 kinase inhibitors in Parkinson Disease
In the translation of discoveries from the laboratory to the clinic, the track record in developing disease-modifying therapies in neurodegenerative disease is poor. A carefully designed development pipeline built from discoveries in both pre-clinical models and patient populations is necessary to o...
Sparad:
| I publikationen: | Exp Neurol |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693612/ https://ncbi.nlm.nih.gov/pubmed/28764903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2017.07.019 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|